training and other support for students, health care providers, and others in the substance use disorder workforce;
prescription drug take-back programs;
surveillance and public health activities to detect and respond to substance use issues;
treatment and recovery services, including for specified populations;
housing services for individuals in treatment and recovery;
drug treatment courts, peer mentoring and wellness support in law enforcement agencies, and other criminal justice activities; and
drug-free community coalitions.
In addition, the bill modifies insurance coverage for substance use disorder drugs and treatments by
prohibiting prior authorizations and other utilization control policies for medication-assisted treatments under Medicaid and private insurance plans, and
requiring Medicare drug plans and private insurance plans to offer at least one opioid reversal drug without cost-sharing.
Furthermore, the bill increases Medicaid payment rates for mental and behavioral health services and requires the federal government to cover the costs of this increase. Additionally, the bill requires that non-opioid treatment options associated with surgery be reimbursed separately, instead of on a packaged basis, under Medicare.
The bill also extends certain Medicaid waivers for delivery reform incentive payments for states that have high rates of drug overdose deaths.